Beinaglutide, a short-acting GLP-1RA with 100% homology to human GLP-1 [6], was approved by the State Drug Administration of China for glycaemic control in adults with type 2 diabetes or adult weight management. Here, GCG is linked to type 2 diabetes mellitus.